Searched for
AHMEDABAD PHARMACEUTICAL COMPANY
India-Japan Annual Summit to focus on AI, chips & clean energyThe two countries have identified semiconductors, critical minerals, pharmaceuticals, clean energy, and information and communication techn...- India-Japan Summit: Deepening economic ties and strategic investment opportunities for next decadePrime Minister Takaichi's visit to India highlights a robust economic partnership, with Japan a key player in India's infrastructure and au...
- Madhusudan Kela-backed fund buys stake in IPO-bound Steamhouse India for Rs 40 croreAce investor Madhusudan Kela's funds, along with Niveshaay Sambhav Fund, have injected Rs 49.99 crore into Steamhouse India via a pre-IPO p...
- RICE Adamas Group expands national footprint with Mumbai Office inaugurationAdamas University and Adamas Tech Consulting have launched a new Mumbai office and the Adamas School of Experiential Learning, offering 10-...
- Smaller cities power India’s corporate travel surgeCorporate travel in India is increasingly shifting towards smaller cities, with nearly 60% of bookings now originating from or heading to t...
- GHIAL remits Rs 12.28 crore interim dividend to Telangana GovernmentGMR Hyderabad International Airport Limited (GHIAL) has sent an interim dividend of approximately Rs 12.28 crore to the Telangana Governmen...
- Dr Reddy’s launches oral semaglutide in IndiaDr Reddys Laboratories has launched its oral semaglutide biosimilar for type 2 diabetes in India. The drug, Obeda, is available in three ta...
- Novartis sharpening India strategy as a pure-play innovatorNovartis India country president and managing director Amitabh Dube said India is gradually moving beyond its traditional role as a clinica...
- NCLAT allows Lyka Labs appeal; asks Modi Lifecare to pay Rs 63 lakh or face insolvency proceedingsThe NCLAT has ruled in favor of Lyka Labs. It overturned a previous NCLT decision. Modi Lifecare Industries must now pay Rs 63 lakh within ...
- Zydus Lifesciences to pursue acquisitions in specialty, rare diseasesZydus Lifesciences is set to acquire US firm Assertio Holdings for $166.40 million. This move aims to build a strong specialty oncology bus...
- Holding stocks is harder than finding them: 10 mid- and small-caps stocks that may be worth holding on toHolding a stock is not an act of blind faith. It is not refusing to change one’s mind. It is not averaging down because the stock has falle...
- Sakar Healthcare Q4 profit up 91% at Rs 11.02 croreSakar Healthcare announced strong financial results for the January-March quarter of 2025-26. Net profit surged by 91 percent to Rs 11.02 c...
- Chinese medicines bring relief to India’s cancer patientsIndia’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...
- ET Family Business Awards: Torrent Pharma drives growth through acquisitions and innovationAman Mehta is guiding Torrent Pharmaceuticals through a significant period of growth and strategic change. He is driving the company's expa...
- US drug maker Baxter opens R&D centre in AhmedabadBaxter said the Ahmedabad R&D centre will help the company to accelerate innovation in generic and differentiated injectable pharmaceutical...
- Doctors in Kashmir plan to boycott Macleods, Intas PharmaMacleods and Intas suspended two medical representatives who posted a Facebook status, considered to be anti-national, post Pulwama attack.
- Claris Lifesciences gets USFDA drug approvalClaris Lifesciences Ltd, a parenteral drug company has received drug approval from US drug authorities for hypertension and angina treatmen...
- HC grants relief to Troikaa in patent case; restrains two firms from selling Dynapar injectionsHC has granted a temporary relief to Troikaa restraining two pharma companies from making & selling the patented versions of diclofenac inj...
- Lincoln sales rise 49% for the financial year 2010-11Ahmedabad-based pharma company, Lincoln Pharmaceuticals Limited (LPL), registered sales growth of 49.72% for the financial year 2010-11.
- Solvay's sourcing from Dishman to cross Rs 100 crSolvay Pharmaceuticals BV the $11bn pharmaceutical major has consistently increased its sourcing from the Ahmedabad-based Dishman Pharmaceu...
Load More
